Clinical trials
Completed Pleural Effusion, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| M.D. Anderson Cancer Center | 3 |
| Naestved Hospital | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| C. R. Bard | 2 |
| Guy's and St Thomas' NHS Foundation Trust | 2 |
| University of Washington | 2 |
| Abnoba Korea | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pleural Effusion, Malignant | 67 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Lung Neoplasms | 12 |
| Neoplasm Metastasis | 8 |
| Pleural Effusion | 7 |
| Breast Neoplasms | 6 |
| Esophageal Neoplasms | 5 |
| Neoplasms | 5 |
| Anus Neoplasms | 4 |
| Carcinoma, Hepatocellular | 4 |
Trials
Showing 76 to 67 of 67. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.